Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 161 Leukemia 99 Lymphoma, Large B-Cell, Diffuse 94 Precursor Cell Lymphoblastic Leukemia-Lymphoma 92 Lymphoma, Non-Hodgkin 91 Leukemia, Myeloid, Acute 76 Hodgkin Disease 73 Lymphoma, Follicular 63 Burkitt Lymphoma 60 Lymphoma, Mantle-Cell 56 Lymphoma, Large-Cell, Immunoblastic 55 Small Cell Lung Carcinoma 46 Leukemia, Lymphocytic, Chronic, B-Cell 42 Lung Neoplasms 41 Neuroblastoma 40 Lymphoma, B-Cell, Marginal Zone 33 Congenital Abnormalities 33 Multiple Myeloma 30 Recurrence 27 Sarcoma 26 Central Nervous System Neoplasms 26 Carcinoma, Non-Small-Cell Lung 25 Myelodysplastic Syndromes 24 Leukemia, Myelomonocytic, Acute 24 Leukemia, Monocytic, Acute 24 Leukemia, Erythroblastic, Acute 24 Testicular Neoplasms 22 Lymphoma, Large-Cell, Anaplastic 22 Leukemia, Megakaryoblastic, Acute 22 Brain Neoplasms 22

Interventions

pembrolizumab 6 Nivolumab 6 Ipilimumab 4 Radiotherapy 3 talimogene laherparepvec 2 budigalimab 2 avelumab 2 atezolizumab 2 Everolimus 2 Cyclophosphamide 2 zimberelimab 1 venetoclax 1 vatalanib 1 tremelimumab 1 temsirolimus 1 sapanisertib 1 rovalpituzumab tesirine 1 poly ICLC 1 oblimersen 1 lorvotuzumab mertansine 1 lanreotide 1 glucopyranosyl lipid-A 1 fludarabine 1 durvalumab 1 domatinostat 1 cixutumumab 1 cemiplimab 1 aldesleukin 1 Vinorelbine 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Merkel Cell × Etoposide × Clear all

NCT01013779 2022-11-18

MP3

Trans Tasman Radiation Oncology Group

Phase 2 Completed

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡